Alexandra Bațani este medic rezident dermatovenerologie la Spitalul Clinic Colentina București
Mihaela Adriana Ghiță este medic rezident dermatovenerologie la Spitalul Clinic Colentina București
Mihaela Vîlcu este medic primar chirurg la Spitalul Clinic „Dr. Ioan Cantacuzino” București și asistent universitar la Departamentul de chirurgie generală al UMF „Carol Davila” București
Daniel Boda este medic primar dermatolog, cercetător științific gradul I. Conduce Centrul de Excelență în Dermatologie din cadrul UMF „Carol Davila” București
Constantin Căruntu este medic specialist dermatologie la Institutul Național de Diabet, Nutriție și Boli Metabolice „Prof. dr. N. Paulescu” și conferențiar universitar la Discipina fiziologie, Facultatea de Moașe și Asistență Medicală, UMF „Carol Davila” București
Bibliografie
1. Tamayo T et al. Diabetes in Europe: an update. Diabetes Res Clin Pract. 2014 Feb;103(2):206-17
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
3. Murphy-Chutorian B et al. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am. 2013 Dec; 42(4):869-98
4. Yosipovitch G et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998 Apr;21(4):506-9.
5. Behm B et al. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012 Oct;26(10):1203-11
6. Levy L, Zeichner JA. Dermatologic manifestation of diabetes. J Diabetes. 2012 Mar;4(1):68-76
7. Quondamatteo F. Skin and diabetes mellitus: what do we know? Cell Tissue Res. 2014 Jan;355(1):1-21
8. Romano G et al. Skin lesions in diabetes mellitus: prevalence and clinical correlations. Diabetes Res Clin Pract. 1998 Feb;39(2):101-6
9. Tsourdi E et al. Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus. Biomed Res Int. 2013;2013:385641
10. Malik RA. Which test for diagnosing early human diabetic neuropathy? Diabetes. 2014 Jul;63(7):2206-8
11. Tesfaye S et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-93
12. Boulton AJ et al. Diabetic somatic neuropathies. Diabetes Care. 2004 Jun;27(6):1458-86
13. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (part 1). Diabetes Care. 1978;1(3):168-88
14. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (part 2). Diabetes Care. 1978 1(4):252-63
15. Vinik AI et al. Diabetic neuropathies. Diabetes Care. 1992 Dec;15(12):1926-75
16. Farmer KL et al. Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev. 2012 Oct;64(4):880-900
17. Edmonds ME, Foster AV. Diabetic foot ulcers. BMJ. 2006 Feb 18;332(7538):407-10
18. Toda M et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother. 2008 Jul-Aug;62(6):352-9
19. Toth CC et al. Locally synthesized calcitonin gene-related Peptide has a critical role in peripheral nerve regeneration. J Neuropathol Exp Neurol. 2009 Mar;68(3):326-37
20. Piérard GE et al. The skin landscape in diabetes mellitus. Focus on dermocosmetic management. Clin Cosmet Investig Dermatol. 2013 May 15;6:127-35
21. Boulton AJ et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005 Apr;28(4):956-62
22. Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S52-7
23. Papanas N, Ziegler D. New diagnostic tests for diabetic distal symmetric polyneuropathy. J Diabetes Complications. 2011 Jan-Feb;25(1):44-51
24. Chantelau E et al. Pressure pain thresholds at the diabetic Charcot-foot: an exploratory study. J Musculoskelet Neuronal Interact. 2012 Jun;12(2):95-101
25. Holman N et al. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012 Jul;55(7):1919-25
26. Dyck PJ et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993 Apr;43(4):817-24
27. Reiber GE et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999 Jan;22(1):157-62
28. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13 Suppl 1:S6-11
29. Abbott CA et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002 May;19(5):377-84
30. Abbott CA et al. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998 Jul;21(7):1071-5
31. National Diabetes Data Group et al. Diabetes in America. 2nd edition. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, 1995
32. Tellechea A et al. Inflammatory and angiogenic abnormalities in diabetic wound healing: role of neuropeptides and therapeutic perspectives. Open Circ Vasc J. 2010;3:43-55
33. Lindberger M et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci. 1989 Nov;93(2-3):289-96
34. Dyck PJ et al. Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies. Diabetes. 2013 Nov;62(11):3677-86
35. Căruntu C et al. Biotechnological advances for diagnosis of peripheral diabetic neuropathy. Rom Biotehnol Let. 2014;19(6):9846-58
36. Krishnan ST et al. Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. Diabetes Care. 2007 Dec;30(12):3058-62
37. Caselli A et al. Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction. J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):927-32
38. Løseth S et al. Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol. 2008 Aug;255(8):1197-202
39. Quattrini C et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007 Aug;56(8):2148-54
40. Căruntu C, Boda D. Evaluation through in vivo reflectance confocal microscopy of the cutaneous neurogenic inflammatory reaction induced by capsaicin in human subjects. J Biomed Opt. 2012 Aug;17(8):085003
41. Altintas MA et al. Insight in human skin microcirculation using in vivo reflectance-mode confocal laser scanning microscopy. J Digit Imaging. 2010 Aug;23(4):475-81
42. Hegyi J et al. Confocal laser-scanning capillaroscopy: a novel approach to the analysis of skin capillaries in vivo. Skin Res Technol. 2009 Nov;15(4):476-81
43. Almodovar JL et al. HIV neuropathy: an in vivo confocal microscopic study. J Neurovirol. 2012 Dec;18(6):503-10
44. Herrmann DN et al. In vivo confocal microscopy of Meissner corpuscles as a measure of sensory neuropathy. Neurology. 2007 Dec 4;69(23):2121-7
45. Price SA et al. Identification of changes in gene expression in dorsal root ganglia in diabetic neuropathy: correlation with functional deficits. J Neuropathol Exp Neurol. 2006 Jul;65(7):722-32
46. Pande M et al. Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. Diabetes. 2011 Jul;60(7):1981-9
47. Hur J et al. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain. 2011 Nov;134(Pt 11):3222-35
48. Tang W et al. Serum biomarker of diabetic peripheral neuropathy indentified by differential proteomics. Front Biosci (Landmark Ed). 2011 Jun 1;16:2671-81
49. Freeman OJ et al. Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy. Diabetes. 2016 Jan;65(1):228-38
50. Akude E et al. Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes. 2011 Jan;60(1):288-97
51. Zhang L et al. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res. 2010 Jan;9(1):458-71
Dacă vrei să fii la curent cu tot ce se întâmplă în lumea medicală, abonează-te la „Viața Medicală”, publicația profesională, socială și culturală a profesioniștilor în Sănătate din România!
Titularii abonamentelor pe 12 luni sunt creditați astfel de:
Cookie-urile ne ajută să vă îmbunătățim experiența pe site-ul nostru. Prin continuarea navigării pe site-ul www.viata-medicala.ro, veți accepta implicit folosirea de cookie-uri pe parcursul vizitei dumneavoastră.
Da, sunt de acord Aflați mai multe